Research Article

You have free access to this content

Effect of childhood cancer treatment on fertility markers in adult male long-term survivors

  1. Niels J. van Casteren MD1,
  2. Geert H.M. van der Linden MD, PhD2,
  3. Friederike G.A.J. Hakvoort-Cammel MD2,
  4. Karel Hählen MD, PhD2,
  5. Gert R. Dohle MD, PhD1,
  6. Marry M. van den Heuvel-Eibrink MD, PhD2,*

Article first published online: 25 SEP 2008

DOI: 10.1002/pbc.21780

Issue

Pediatric Blood & Cancer

Pediatric Blood & Cancer

Volume 52, Issue 1, pages 108–112, January 2009

Additional Information

How to Cite

van Casteren, N. J., van der Linden, G. H.M., Hakvoort-Cammel, F. G.A.J., Hählen, K., Dohle, G. R. and van den Heuvel-Eibrink, M. M. (2009), Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr. Blood Cancer, 52: 108–112. doi: 10.1002/pbc.21780

Author Information

  1. 1

    Section of Andrology, Department of Urology, Erasmus MC–University Medical Center, Rotterdam, The Netherlands

  2. 2

    Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands

*Associate Professor in Pediatric Oncology/Hematology, Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Room Sp-2568, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands.

Publication History

  1. Issue published online: 12 NOV 2008
  2. Article first published online: 25 SEP 2008
  3. Manuscript Accepted: 19 AUG 2008
  4. Manuscript Received: 8 MAY 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (101K)

REFERENCES

  • 1
    Gatta G, Capocaccia R, Stiller C, et al. Childhood cancer survival trends in Europe: A EUROCARE Working Group study. J Clin Oncol 2005; 23: 3742–3751.
  • 2
    Bleyer WA. The impact of childhood cancer on the United States and the World. CA Cancer J Clin 1990; 40: 355–367.
    Direct Link:
  • 3
    Meadows AT. Pediatric cancer survivorship: Research and clinical care. J Clin Oncol 2006; 24: 5160–5165.
  • 4
    Brougham MF, Kelnar CJ, Sharpe RM, et al. Male fertility following childhood cancer: Current concepts and future therapies. Asian J Androl 2003; 5: 325–337.
  • 5
    Cicognani A, Cacciari E, Pasini A, et al. Low serum inhibin B levels as a marker of testicular damage after treatment for a childhood malignancy. Eur J Pediatr 2000; 159: 103–107.
  • 6
    Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 1996; 27: 74–78.
    Direct Link:
  • 7
    Wallace WH, Shalet SM, Lendon M, et al. Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. Int J Androl 1991; 14: 312–319.
    Direct Link:
  • 8
    Wallace WH, Shalet SM, Crowne EC, et al. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 1989; 17: 409–413.
    Direct Link:
  • 9
    Chemes HE. Infancy is not a quiescent period of testicular development. Int J Androl 2001; 24: 2–7.
    Direct Link:
  • 10
    Pierik FH, Vreeburg JT, Stijnen T, et al. Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab 1998; 83: 3110–3114.
  • 11
    Kumanov P, Nandipati K, Tomova A, et al. Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertil Steril 2006; 86: 332–338.
  • 12
    Klingmuller D, Haidl G. Inhibin B in men with normal and disturbed spermatogenesis. Hum Reprod 1997; 12: 2376–2378.
  • 13
    Jensen TK, Andersson AM, Hjollund NH, et al. Inhibin B as a serum marker of spermatogenesis: Correlation to differences in sperm concentration and follicle-stimulating hormone levels. A. study of 349 Danish men. J Clin Endocrinol Metab 1997; 82: 4059–4063.
  • 14
    Pierik FH, Burdorf A, de Jong FH, et al. Inhibin B: A novel marker of spermatogenesis. Ann Med 2003; 35: 12–20.
  • 15
    van Beek R, Smit M, van den Heuvel-Eibrink M, et al. Inhibin B is superior to FSH as a marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. Hum Reprod 2007; 22: 3215–3222.
  • 16
    Meachem SJ, Nieschlag E, Simoni M. Inhibin B in male reproduction: Pathophysiology and clinical relevance. Eur J Endocrinol 2001; 145: 561–571.
  • 17
    Stewart J, Turner KJ. Inhibin B as a potential biomarker of testicular toxicity. Cancer Biomark 2005; 1: 75–91.
  • 18
    WHO. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, Fourth edition. Cambridge, UK: Cambridge University Press; 1999.
  • 19
    van Casteren NJ, Dohle GR, Romijn JC, et al. Semen cryopreservation in pubertal boys before gonadotoxic treatment and the role of endocrinologic evaluation in predicting sperm yield. Fertil Steril 2007; Sept 28 (in press).
  • 20
    Relander T, Cavallin-Stahl E, Garwicz S, et al. Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 2000; 35: 52–63.
    Direct Link:
  • 21
    Crofton PM, Thomson AB, Evans AE, et al. Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer? Clin Endocrinol (Oxf) 2003; 58: 296–301.
    Direct Link:
  • 22
    Thomson AB, Campbell AJ, Irvine DC, et al. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: A case-control study. Lancet 2002; 360: 361–367.
  • 23
    Brougham MF, Wallace WH. Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol 2005; 131: 143–155.
  • 24
    Watson AR, Rance CP, Bain J. Long term effects of cyclophosphamide on testicular function. Br Med J (Clin Res Ed) 1985; 291: 1457–1460.
  • 25
    Muller J. Impact of cancer therapy on the reproductive axis. Horm Res 2003; 59: 12–20.
  • 26
    Trottmann M, Becker AJ, Stadler T, et al. Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation. Eur Urol 2007; 52: 355–367.
  • 27
    van den Berg H, Furstner F, van den Bos C, et al. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatr Blood Cancer 2004; 42: 210–215.
    Direct Link:
  • 28
    Ash P. The influence of radiation on fertility in man. Br J Radiol 1980; 53: 271–278.
  • 29
    Castillo LA, Craft AW, Kernahan J, et al. Gonadal function after 12-Gy testicular irradiation in childhood acute lymphoblastic leukaemia. Med Pediatr Oncol 1990; 18: 185–189.
    Direct Link:
  • 30
    Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, et al. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996; 129: 544–550.
  • 31
    Rey RA, Campo SM, Bedecarras P, et al. Is infancy a quiescent period of testicular development? Histological, morphometric, and functional study of the seminiferous tubules of the cebus monkey from birth to the end of puberty. J Clin Endocrinol Metab 1993; 76: 1325–1331.
  • 32
    Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988; 259: 2123–2125.
  • 33
    Howell SJ, Shalet SM. Effect of cancer therapy on pituitary-testicular axis. Int J Androl 2002; 25: 269–276.
    Direct Link:
  • 34
    Kelnar CJ, McKinnell C, Walker M, et al. Testicular changes during infantile ‘quiescence’ in the marmoset and their gonadotrophin dependence: A model for investigating susceptibility of the prepubertal human testis to cancer therapy? Hum Reprod 2002; 17: 1367–1378.
  • 35
    Schmiegelow ML, Sommer P, Carlsen E, et al. Penile vibratory stimulation and electroejaculation before anticancer therapy in two pubertal boys. J Pediatr Hematol Oncol 1998; 20: 429–430.
View Full Article with Supporting Information (HTML) Get PDF (101K)